Trial intelligence / Profile preview

Flavopiridol in Soft Tissue Sarcoma

NCT00005974Phase 2Completed

Sponsor
Canadian Cancer Trials Group
Start
Jul 2000
Primary completion
Nov 2002
Modality
Orthosteric Ligands
Countries
2
01

Overview

A Phase 2 trial of alvocidib in soft tissue sarcoma (STS), sponsored by Canadian Cancer Trials Group. Started Jul 2000; status: completed.

02

Drugs

alvocidib
03

Conditions

soft tissue sarcoma (STS)

Beyond the preview

Go deeper on NCT00005974.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00005974.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call